Filing Flows › Firefly Neuroscience (AIFF) › R&D spending
Firefly Neuroscience (AIFF) R&D spending by quarter
Firefly Neuroscience's R&D spending was $525K in Q2 2026 (second quarter 2026), +24% from Q1 2026. Over the last 7 quarters it ranged from $312K (Q1 2025) to $525K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $525K | +24% | +56% |
| Q1 2026 | $424K | -7% | +36% |
| Q4 2025 | $456K | +21% | +4% |
| Q3 2025 | $378K | +12% | — |
| Q2 2025 | $336K | +8% | — |
| Q1 2025 | $312K | -29% | — |
| Q4 2024 | $437K | — | — |
Q2 2026 at a glance
Firefly Neuroscience, Q2 2026: revenue $514K (+72% year over year), operating margin -384.0%, net loss $2.0M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Firefly Neuroscience's R&D spending?
Firefly Neuroscience's R&D spending was $525K in Q2 2026 (second quarter 2026), +24% from Q1 2026.
How has Firefly Neuroscience's R&D spending changed?
Over the last 7 quarters it ranged from $312K (Q1 2025) to $525K (Q2 2026).